Evidence map›Paper›PMID 27001617›Full record

ArticleMolecular psychiatry2017

System-based proteomic and metabonomic analysis of the Df(16)A

H Wesseling, B Xu, E J Want, E Holmes, P C Guest, M Karayiorgou, J A Gogos, S Bahn

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. AUGMENTED DOUBLY ROBUST POST-IMPUTATION INFERENCE FOR PROTEOMIC DATA.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. 22q11.2 Deletion Syndrome-Associated Parkinson's Disease.Movement disorders clinical practice · 2019
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

H WesselingDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
B XuDepartment of Psychiatry, Columbia University, New York, NY, USA.
E J WantSection of Biomolecular Medicine, Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, UK.
E HolmesSection of Biomolecular Medicine, Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, UK.
P C GuestDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
M KarayiorgouDepartment of Psychiatry, Columbia University, New York, NY, USA.
J A GogosDepartment of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.
S BahnDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Columbia University · USUniversity of Cambridge · GBImperial College London · GB

Funding

Functional Analysis of the 22q11.2 schizophrenia susceptibility genesR01MH067068 · NIMH · ROCKEFELLER UNIVERSITY · PI KARAYIORGOU, MARIA · 2003 to 2017
$7.5M
Elucidation of gene networks underlying susceptibility to schizophreniaR01MH077235 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2007 to 2009
$1.3M
Integrative methods for the identification of causal variants in mental disorderR01MH106910 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IONITA, IULIANA, XU, BIN · 2016 to 2018
$1.2M
NIMH NIH HHS R01 MH067068NIMH NIH HHS R01 MH077235NIMH NIH HHS R01 MH106910
6 · The paper itself

Abstract

Deletions on chromosome 22q11.2 are a strong genetic risk factor for development of schizophrenia and cognitive dysfunction. We employed shotgun liquid chromatography-mass spectrometry (LC-MS) proteomic and metabonomic profiling approaches on prefrontal cortex (PFC) and hippocampal (HPC) tissue from Df(16)A

Indexed as

AnimalsBrainChromatography, LiquidChromosome DeletionDiGeorge SyndromeDisease Models, AnimalHippocampusHumansMaleMass SpectrometryMetabolomicsMiceMice, TransgenicMicroRNAsPrefrontal CortexProteomicsMicroRNAsMIRN185 microRNA, human

Identifiers

PMID27001617
PMCPMC5322275
OpenAlexW2305391551

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.